European Commission Approves Tafasitamab Combo in R/R Follicular Lymphoma
In major medical news, the European Commission has signed off on the use of Tafasitamab in combination with lenalidomide for adults suffering from recurrent or refractory follicular lymphoma.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
The FDA has granted a ‘Fast Track Designation’ to SRN-101 for the treatment of recurrent high-grade glioma, marking a significant step forward in battling this aggressive disease.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
In ongoing advancements, a novel small molecule is exhibiting promising early activity in the fight against pretreated multiple myeloma, a type of blood cancer.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
Noteworthy findings have emerged in the study of OPSCC treatments, with research comparing quality of life outcomes when using protons versus photons.
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer
Key insights are provided in prostate cancer treatment, with revelations around PSMA-Directed Imaging and Radioligand Therapy making strides in the treatment of this pervasive disease.
Characterizing TILs in Pancreatic NET Liver Metastases
In advances within liver metastasis treatment, the spotlight is on the characterization of TILs in pancreatic NET liver metastases.
